Gilead announces FDA acceptance of lenacapavir NDA submissions
Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly injectable ...
Deutsche upgrades Gilead to Buy on ability to offset patent cliffs
Deutsche Bank upgraded Gilead (GILD) to Buy from Hold with a price target of $120, up from $80. The company’s core HIV treatment franchise ...
Gilead got D'Arcy Carden
Dave Bautista recently commented on the possibility of his return as Drax the Destroyer in Guardians of the Galaxy 4 in the future. In 2023, Marvel Studios’ Guardians of the Galaxy 3 ended with the ...
S&P 500 Ends Down as Hot US Inflation Data Hints at Fewer Rate Cuts
According to preliminary data, the S&P 500 lost 16.58 points, or 0.28%, to end at 6,051.92 points, while the Nasdaq Composite ...
Stock Market Today: Most of Wall Street Sinks After Inflation Worsens
Asian shares mostly rose Wednesday, as regional markets continued to watch President Donald Trump’s latest tariff escalation ...
Gilead Quarterly Results Beat Estimates
Gilead said its fourth-quarter HIV product sales rose to $5.45 billion from $4.69 billion a year earlier, due to higher ...
Diginomica8d
Agents of change - Salesforce's new top team for the 'Agentforce era'
Salesforce has announced a new CFO+ with an expanded set of responsibilities as a company veteran who "bleeds CRM" prepares ...
U.S. News & World Report12d
Biden Rule Cleared Hurdles to Lifesaving HIV Drug, but Barriers Remain in Georgia
Georgia has big racial and gender discrepancies in PrEP uptake, said Patrick Sullivan, who is an epidemiology professor at ...
BioSpace28d
Almost 5 Years into $5B Galapagos Partnership, Gilead Execs Start Over With New Spinoff
Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing. Gilead had reached an inflection point ...